ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China · Delayed Price · Currency is CNY 9.61
0.00 (0.00%)
Jul 3, 2026, 3:00 PM CST
SHA:600479 Revenue
ZhuZhou QianJin Pharmaceutical Co.,Ltd had revenue of 970.27M CNY in the quarter ending March 31, 2026, a decrease of -3.46%. This brings the company's revenue in the last twelve months to 3.59B, down -1.10% year-over-year. In the year 2025, ZhuZhou QianJin Pharmaceutical Co.,Ltd had annual revenue of 3.63B, down -0.03%.
Revenue (ttm)
3.59B
Revenue Growth
-1.10%
P/S Ratio
1.32
Revenue / Employee
712.97K
Employees
5,041
Market Cap
4.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.63B | -961.39K | -0.03% |
| Dec 31, 2024 | 3.63B | -168.68M | -4.44% |
| Dec 31, 2023 | 3.80B | -227.79M | -5.66% |
| Dec 31, 2022 | 4.03B | 362.43M | 9.89% |
| Dec 31, 2021 | 3.66B | 36.88M | 1.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HPGC Renmintongtai Pharmaceutical | 10.54B |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.68B |
| Zhejiang Starry Pharmaceutical | 2.47B |
| Beijing Beilu Pharmaceutical | 1.24B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.04B |
| Teyi Pharmaceutical Group Co.,Ltd | 839.27M |
| Nanjing Hicin Pharmaceutical | 688.74M |
| Zhongzhu Healthcare Holding Co.,Ltd | 544.73M |